{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:35:16Z","timestamp":1772544916465,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clinthera.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T23:46:26Z","timestamp":1420674386000},"page":"418-426","source":"Crossref","is-referenced-by-count":27,"title":["Assessment of Montelukast, Doxofylline, and Tiotropium With Budesonide for the Treatment of Asthma: Which Is the Best Among the Second-line Treatment? A Randomized Trial"],"prefix":"10.1016","volume":"37","author":[{"given":"Muhasaparur Ganesan","family":"Rajanandh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcot D.","family":"Nageswari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaliappan","family":"Ilango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.12.008_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinthera.2014.02.006","article-title":"Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline and tiotropium with budesonide: a randomized controlled study","volume":"36","author":"Rajanandh","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2014.12.008_bib2","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jaci.2011.12.988","article-title":"Asthma outcomes: quality of life","volume":"129","author":"Wilson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2014.12.008_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/rmed.2000.0972","article-title":"Comparison between formoterol 12 mg b.i.d. and on demand salbutamol in moderate persistent asthma","volume":"95","author":"Molimard","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.clinthera.2014.12.008_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3132\/pcrj.2008.00067","article-title":"Summary of the 2008 BTS\/SIGN British Guideline on the management of asthma","volume":"18","author":"Levy","year":"2009","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.clinthera.2014.12.008_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jecm.2014.03.008","article-title":"Influence of demographic status on pulmonary function, quality of life and symptom scores in patients with mild to moderate persistent asthma","volume":"6","author":"Rajanandh","year":"2014","journal-title":"J Exp Clin Med"},{"key":"10.1016\/j.clinthera.2014.12.008_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2014.12.008_bib7","first-page":"309","article-title":"Development and validation of knowledge, attitude, practice questionnaire for asthma and assessment of impact of patient education on asthma patients","volume":"6","author":"Rajanandh","year":"2014","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.clinthera.2014.12.008_bib8","first-page":"276","article-title":"Does dose reduction of an inhaled corticosteroid with the addition of leukotriene antagonist is clinical significance in asthma patients? a randomized clinical trial","volume":"24","author":"Rajanandh","year":"2013","journal-title":"World Appl Sci J"},{"key":"10.1016\/j.clinthera.2014.12.008_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaci.2004.03.034","article-title":"The role of the mast cell in asthma: induction of airway hyper responsiveness by interaction with smooth muscle?","volume":"114","author":"Robinson","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2014.12.008_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3923\/jms.2014.81.86","article-title":"Effect of two controller medications with inhaled corticosteroid in mild to moderate persistent asthma patients","volume":"14","author":"Rajanandh","year":"2014","journal-title":"J Med Sci"},{"key":"10.1016\/j.clinthera.2014.12.008_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2009\/145071","article-title":"Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (The RADAR Trial)","volume":"16","author":"Keith","year":"2009","journal-title":"Can Respir J"},{"key":"10.1016\/j.clinthera.2014.12.008_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.rmed.2009.11.022","article-title":"Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study","volume":"104","author":"Virchow","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.clinthera.2014.12.008_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/thx.2007.081596","article-title":"Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review","volume":"63","author":"Joos","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.clinthera.2014.12.008_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/1440-1681.12239","article-title":"Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized controlled trial","volume":"41","author":"Rajanandh","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.clinthera.2014.12.008_bib15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa053614","article-title":"CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma","volume":"354","author":"Akbari","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2014.12.008_bib16","first-page":"11","article-title":"Tiotropium in asthma: a systematic review","volume":"7","author":"Befekadu","year":"2014","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.clinthera.2014.12.008_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11596-011-0570-5","article-title":"Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease","volume":"31","author":"Wang","year":"2011","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"10.1016\/j.clinthera.2014.12.008_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2014.12.008_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1513\/pats.200808-087RM","article-title":"Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies","volume":"6","author":"Fahy","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.clinthera.2014.12.008_bib20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1183\/09031936.00014108","article-title":"Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype","volume":"31","author":"Iwamoto","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinthera.2014.12.008_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3346\/jkms.2007.22.5.839","article-title":"The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease","volume":"22","author":"Um","year":"2007","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinthera.2014.12.008_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1164\/ajrccm.163.4.2008014","article-title":"Clinical predictors of health-related quality of life depend on asthma severity","volume":"163","author":"Moy","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2014.12.008_bib23","first-page":"86","article-title":"Quality of life assessment in asthmatic patients receiving fluticosone compared with equipotent doses of beclomethasone or budesonide","volume":"22","author":"Thomas","year":"2005","journal-title":"Lung India"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T08:29:50Z","timestamp":1537950590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814008285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0149291814008285"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.12.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}